XBP Global Q2 Results: Normalized EBITDA Jumps 41% QoQ to $21.9 million
XBP Global Holdings reported Q2 2026 normalized EBITDA of $21.9 million, up 41% QoQ, as adjusted gross margins hit a record 24.9%. Total revenue fell 14% YoY to $191.3 million due to legacy contract exits, but TCV grew 51.6% YoY to $121.3 million. The company targets $65-75 million in annualized efficiencies via AI automation and workforce optimization.

*this image is generated using AI for illustrative purposes only.
XBP Global Holdings (NASDAQ: XBP) delivered its strongest profitability metrics to date in the second quarter of 2026, reporting normalized EBITDA of $21.9 million and an adjusted gross margin of 24.9%. This performance occurred against a backdrop of declining top-line revenue, which fell 14% year over year to $191.3 million, reflecting the planned exit of lower-margin legacy contracts.
The divergence between falling revenue and rising profitability highlights the company's strategic shift from volume-heavy business process services to high-margin, AI-driven workflow automation. While total revenue contracted, the company’s operating leverage improved significantly, with normalized EBITDA rising 40.6% sequentially and expanding to an 11.5% margin.
Financial Performance
Revenue declined due to expected client exits and volume reductions tied to prior restructuring efforts. However, margin expansion was robust across segments:
| Metric: | Q2 2026 Value | Change | Note |
|---|---|---|---|
| Total Revenue: | $191.3 million | -14% YoY | Pro forma basis |
| Normalized EBITDA: | $21.9 million | +8.4% YoY | +40.6% QoQ |
| Adjusted Gross Margin: | 24.9% | +290 bps YoY | Highest level to date |
| Reported Gross Margin: | 21.5% | +80 bps YoY | Includes one-time charges |
The Applied Workflow Automation segment, which generated $166.8 million in revenue (down 16.7% YoY), saw its adjusted gross margin expand by 120 basis points to 19.2%. The Technology segment contributed $24.5 million in revenue, up 9.8% YoY, with adjusted gross margin surging 690 basis points to 64.2%.
What the Numbers Show
The data reveals a structural decoupling of headcount from revenue generation. Revenue per employee rose to approximately $89,000, up from $82,000 in the previous quarter, significantly outpacing the peer group average of roughly $60,000. This efficiency gain supports the company’s guidance for annualized operational efficiencies of $65–75 million, driven by a projected 20% workforce reduction by year-end and non-payroll initiatives such as third-party vendor savings.
Commercial Momentum
Despite the revenue contraction, forward-looking commercial indicators strengthened considerably:
- Total Contract Value (TCV): Closed deals worth $121.3 million, representing a 51.6% increase year over year and a 12.2% sequential rise.
- New Annual Contract Value (ACV): Reached $36 million, up 57% YoY and 32.1% sequentially.
- Pipeline: Stood at $2.5 billion as of June 30, flat with Q1 but up 17.2% YoY.
Demand is concentrating in heavily regulated sectors such as Healthcare and the Public Sector, where clients prioritize secure, on-premise hyper-automation with strict data sovereignty. The company noted low client concentration, with the top 10 clients accounting for only 34% of revenues and an average tenure of 15 years among the top 25 clients.
Strategic Outlook
Management emphasized that the current trajectory validates the transition to an "AI-first" operating model. The company plans to continue leveraging open-weight models to integrate rapidly into deployed agentic AI pipelines, ensuring compliance with regulations like the EU AI Act. XBP Global Holdings also confirmed it has engaged a financial advisor regarding strategic alternatives announced last quarter.
How will the engagement of a financial advisor for strategic alternatives impact investor confidence in XBP's long-term AI transformation strategy versus potential acquisition scenarios?
Given the 20% projected workforce reduction, what specific risks does XBP face regarding talent retention and institutional knowledge loss during the transition to an AI-first operating model?
Will the strong demand in regulated sectors like Healthcare and Public Sector be sufficient to offset the continued decline in legacy revenue, or will XBP need to accelerate sales in less regulated industries to stabilize top-line growth?
























